{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:25:49Z","timestamp":1789129549378,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019191","name":"Portuguese Cardiology Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.repc.2026.05.004","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:05:19Z","timestamp":1784588719000},"page":"529-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ramping ubiquitinomics for the design of new sex-specific therapeutic strategies for aortic valve stenosis: Study protocol"],"prefix":"10.1016","volume":"45","author":[{"given":"F\u00e1bio","family":"Trindade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Grego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seabra-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Sousa-Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nogueira-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Marisa Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2026.05.004_bib0185","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","article-title":"Contemporary presentation and management of valvular heart disease","volume":"140","author":"Iung","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.repc.2024.11.006","article-title":"Strategic plan for cardiovascular health in Portugal \u2013 Portuguese Society of Cardiology (PESCP-SPC)","volume":"44","author":"Cabral","year":"2025","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2026.05.004_bib0195","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.repc.2026.05.004_bib0200","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2026.05.004_bib0205","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2026.05.004_bib0210","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.amjcard.2008.04.060","article-title":"Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20mg)","volume":"102","author":"Dichtl","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2026.05.004_bib0215","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis","volume":"121","author":"Leung","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0220","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis-Gravel","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0225","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0230","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.123.066523","article-title":"Reactivation of oxidized soluble guanylate cyclase as a novel treatment strategy to slow progression of calcific aortic valve stenosis: preclinical and randomized clinical trials to assess safety and efficacy","volume":"151","author":"Zhang","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0235","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jacc.2024.06.037","article-title":"Effect of evogliptin on the progression of aortic valvular calcification","volume":"84","author":"Song","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2026.05.004_bib0240","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/nu10040386","article-title":"Bicuspid aortic valve stenosis and the effect of vitamin K2 on calcification using 18F-sodium fluoride positron emission tomography\/magnetic resonance: the BASIK2 Rationale and Trial Design","volume":"10","author":"Peeters","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.repc.2026.05.004_bib0245","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/CIRCULATIONAHA.116.027011","article-title":"Slower progress of aortic valve calcification with vitamin K supplementation","volume":"135","author":"Brandenburg","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0250","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.121.057008","article-title":"Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial","volume":"145","author":"Diederichsen","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0255","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ehjci\/jeaa065","article-title":"Association of aortic valve calcification and vitamin K antagonist treatment","volume":"21","author":"S\u00f8nderskov","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.repc.2026.05.004_bib0260","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","article-title":"Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis","volume":"120","author":"Louis","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.repc.2026.05.004_bib0265","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2026.05.004_bib0270","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/ATVBAHA.118.311504","article-title":"Calcification induced by type I interferon in human aortic valve interstitial cells is larger in males and blunted by a Janus kinase inhibitor","volume":"38","author":"Iv\u00e1n","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.repc.2026.05.004_bib0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00380-016-0909-8","article-title":"Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells","volume":"32","author":"Masjedi","year":"2017","journal-title":"Heart Vessels"},{"key":"10.1016\/j.repc.2026.05.004_bib0280","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12014-025-09549-1","article-title":"Dissecting sexual dimorphism in aortic valve stenosis by proteomics","volume":"22","author":"Grego","year":"2025","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.repc.2026.05.004_bib0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacbts.2020.11.008","article-title":"Proteomic architecture of valvular extracellular matrix: FNDC1 and MXRA5 are new biomarkers of aortic stenosis","volume":"6","author":"Bouchareb","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.repc.2026.05.004_bib0290","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3706","article-title":"Nitric oxide prevents aortic valve calcification by S-nitrosylation of USP9X to activate NOTCH signaling","volume":"7","author":"Majumdar","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.repc.2026.05.004_bib0295","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00395-025-01125-w","article-title":"Myocardial phosphoproteomics unveils a key role of DYRK1A in aortic valve replacement-induced reverse remodelling","volume":"120","author":"Trindade","year":"2025","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.repc.2026.05.004_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103215","article-title":"FOXO1 regulates RUNX2 ubiquitination through SMURF2 in calcific aortic valve disease","volume":"73","author":"Jiang","year":"2024","journal-title":"Redox Biol"},{"key":"10.1016\/j.repc.2026.05.004_bib0305","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1093\/eurheartj\/ehab316","article-title":"DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2026.05.004_bib0310","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.116.024270","article-title":"Dipeptidyl peptidase-4 induces aortic valve calcification by inhibiting insulin-like growth factor-1 signaling in valvular interstitial cells","volume":"135","author":"Choi","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2026.05.004_bib0315","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.repc.2026.05.004_bib0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43556-022-00112-0","article-title":"An overview of PROTACs: a promising drug discovery paradigm","volume":"3","author":"Liu","year":"2022","journal-title":"Mol Biomed"},{"key":"10.1016\/j.repc.2026.05.004_bib0325","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.apsb.2020.11.001","article-title":"Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo","volume":"11","author":"Luo","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.repc.2026.05.004_bib0330","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/s41401-023-01088-5","article-title":"Bioinspired PROTAC-induced macrophage fate determination alleviates atherosclerosis","volume":"44","author":"Huang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.repc.2026.05.004_bib0335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1747-1028-5-19","article-title":"Mechanisms of mono- and poly-ubiquitination: ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine","volume":"5","author":"Sadowski","year":"2010","journal-title":"Cell Div"},{"key":"10.1016\/j.repc.2026.05.004_bib0340","doi-asserted-by":"crossref","first-page":"D1510","DOI":"10.1093\/nar\/gkae768","article-title":"PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters","volume":"53","author":"Ge","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.repc.2026.05.004_bib0345","article-title":"Animal models of calcific aortic valve disease","volume":"2011","author":"Sider","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1016\/j.repc.2026.05.004_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.repc.2026.05.004_bib0355","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes10030030","article-title":"Optimization of a protocol for protein extraction from calcified aortic valves for proteomics applications: development of a standard operating procedure","volume":"10","author":"Trindade","year":"2022","journal-title":"Proteomes"},{"key":"10.1016\/j.repc.2026.05.004_bib0360","doi-asserted-by":"crossref","DOI":"10.3791\/62439","article-title":"Isolation of human primary valve cells for in vitro disease modeling","author":"Cuevas","year":"2021","journal-title":"J Vis Exp"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255126002325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255126002325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:21:06Z","timestamp":1789125666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255126002325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0870255126002325"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2026.05.004","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ramping ubiquitinomics for the design of new sex-specific therapeutic strategies for aortic valve stenosis: Study protocol","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2026.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}